Letitia H. Swortwood
President chez Western States Investment Corp.
Profil
Letitia H.
Swortwood is currently the President of Western States Investment Corp.
She previously worked as a Principal at Lpath, Inc.
Postes actifs de Letitia H. Swortwood
| Sociétés | Poste | Début |
|---|---|---|
Western States Investment Corp.
 Western States Investment Corp. Investment ManagersFinance Western States Investment Corp ( Western States Investment ) is a private equity firm founded in 1976. The firm is headquartered in San Diego, California. | President | - |
Anciens postes connus de Letitia H. Swortwood
| Sociétés | Poste | Fin |
|---|---|---|
Lpath, Inc.
 Lpath, Inc. BiotechnologyHealth Technology Lpath, Inc. operates as a biotechnology company, which focuses on the discovery and development of lipidomic-based therapeutic antibodies, an emerging field of medical science that targets bioactive signaling lipids to treat a wide range of human diseases. It develops three drug candidates, each of them into clinical trials, and built evidence to support their approach of targeting bioactive lipids to treat a wide range of diseases. The company was founded by Roger Allen Sabbadini in September 1997 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Western States Investment Corp.
Western States Investment Corp. Investment ManagersFinance Western States Investment Corp ( Western States Investment ) is a private equity firm founded in 1976. The firm is headquartered in San Diego, California. | Finance |
Lpath, Inc.
Lpath, Inc. BiotechnologyHealth Technology Lpath, Inc. operates as a biotechnology company, which focuses on the discovery and development of lipidomic-based therapeutic antibodies, an emerging field of medical science that targets bioactive signaling lipids to treat a wide range of human diseases. It develops three drug candidates, each of them into clinical trials, and built evidence to support their approach of targeting bioactive lipids to treat a wide range of diseases. The company was founded by Roger Allen Sabbadini in September 1997 and is headquartered in San Diego, CA. | Health Technology |
